Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Abstract

Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.

K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;
K Meyer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Fobker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
U Christians
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Erren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K F Sewing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G Assmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Benninghoven
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 24 no. 10 1151-1154
PubMed 
8894518

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Published online October 1, 1996.


Author Information

  1. K Meyer,
  2. M Fobker,
  3. U Christians,
  4. M Erren,
  5. K F Sewing,
  6. G Assmann and
  7. A Benninghoven
  1. Physikalisches Institut der Universität Münster, Germany.

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to May 2023

    AbstractFullPdf
    Aug 2017600
    Sep 2017500
    Oct 20171200
    Nov 2017800
    Dec 2017200
    Jan 2018900
    Feb 20181502
    Mar 2018600
    Apr 2018200
    May 2018700
    Jun 2018301
    Jul 2018400
    Aug 2018800
    Sep 2018100
    Oct 2018501
    Nov 2018700
    Dec 2018300
    Jan 2019100
    Feb 20191600
    Mar 2019900
    Apr 2019400
    May 2019500
    Jun 2019302
    Jul 2019200
    Aug 2019700
    Oct 2019200
    Nov 2019200
    Dec 2019800
    Jan 2020300
    Feb 2020600
    Mar 2020301
    May 2020100
    Jun 2020100
    Jul 2020300
    Aug 2020102
    Sep 2020200
    Oct 2020200
    Nov 2020100
    Dec 2020400
    Jan 2021700
    Feb 2021601
    Mar 2021900
    Apr 2021501
    May 2021501
    Jun 2021400
    Jul 2021600
    Aug 2021500
    Sep 2021100
    Oct 2021600
    Nov 20211400
    Dec 2021600
    Jan 2022300
    Feb 2022200
    Mar 2022200
    Apr 2022300
    May 2022500
    Jun 2022800
    Jul 20221500
    Aug 2022500
    Sep 2022700
    Oct 20221400
    Nov 2022700
    Dec 20221100
    Jan 2023300
    Feb 20231003
    Mar 2023500
    Apr 2023200
    May 20231600

    PreviousNext
    Back to top

    In this issue

    Drug Metabolism and Disposition
    Vol. 24, Issue 10
    1 Oct 1996
    • Table of Contents
    • Table of Contents (PDF)
    • Index by author
    • Back Matter (PDF)
    • Editorial Board (PDF)
    • Front Matter (PDF)
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Drug Metabolism & Disposition article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
    (Your Name) has forwarded a page to you from Drug Metabolism & Disposition
    (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Abstract

    Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.

    K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
    Drug Metabolism and Disposition October 1, 1996, 24 (10) 1151-1154;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Abstract

    Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.

    K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
    Drug Metabolism and Disposition October 1, 1996, 24 (10) 1151-1154;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About DMD
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-009X (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics